Home > Pressrelease > Mice Model Market size worth over $12.3 Bn by 2026

Mice Model Market size worth over $12.3 Bn by 2026

  • Published Date: December 16, 2020

Mice Model Market size is set to surpass USD 12.3 billion by 2026, according to a new research report by Global Market Insights Inc.

The demand for mice model in biomedical research is primarily due to genetic similarity between mice and humans that is driving the market growth. Mice share more than 95% of genetic content with humans, hence, there is a huge demand among researchers to study human diseases on these models. Mice model are booming in the area of immunology research, since these models are frequently used to mimic autoimmune diseases such as diabetes mellitus and multiple sclerosis. Owing to these genetic similarities, the number of mice model used in research is growing.

Growing demand for knockout mice will augment the market expansion

Global Mice Model Market

Get more details on this report - Request Free Sample PDF

Knockout mice type will showcase growth rate of 7.4% till 2026 on account of several applications of knockout mice in studying the different research areas such as cancer, heart diseases, diabetes, arthritis, Parkinson’s disease, anxiety among others. For instance, Frantic knockout model is extensively used to study anxiety disorders. Knockout model provides information pertaining to normal functioning of knocked-out genes, including the gene's biochemical, developmental, physical, and behavioral roles. Moreover, knockout mice are often used to discover the function of human genes.

Browse key industry insights spread across 366 pages with 749 market data tables & 20 figures & charts from the report, Mice Model Market Size By Mice Type (Inbred, Outbred, Knockout, Hybrid), By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), By Application (Research and Development, {Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases}, Production and Quality Control, Academics), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-government}, Academic and Research Institutes, Contract Research Organizations (CROs)), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026in detail along with the table of contents:


Rising preference for embryonic stem cell injection technology will enhance the market revenue

Embryonic stem cell injection segment valued at more than USD 1.1 billion in 2019 led by increase in production of embryonic stem cell derived mutant mice to study molecular genetics and developmental biology. Embryonic stem cell injection in mice has enabled the production of individual specific embryonic stem cell lines in several species for potential cell-replacement therapy.  Cost-effective and time-saving are some other attributes that are propelling the demand for embryonic stem cell injection.

Increasing interest in research and development will foster the market demand

The research and development segment crossed USD 5.3 billion in 2019 impelled by the growing interest in the research of immunology diseases, cancer, obesity among others. Rising need to develop treatment methods through research for infectious diseases, cardiovascular diseases, diabetes, neurological disease, etc. is fostering the demand for these models.

Growing prevalence of chronic disorders in humans will drive the market value

Human segment in the mice model market exceeded USD 6.1 billion in 2019 propelled by the factors such as increasing focus towards studying immune responses and therapies, human-specific infections along with identification of the efficacy and safety of drugs on humans. The usage of mice model that share more than 90% genetic content with humans for understanding several diseases such as diabetes, cardiovascular diseases, and neurological diseases is boosting the segment growth. Mice model are fundamental in clinical research for determining the pharmacodynamics and pharmacokinetics of the drugs used in the treatment of human diseases.

Rising adoption of mice models by contract research organizations will impact the market expansion

Contract research organizations (CRO) end-use segment is estimated to attain a CAGR of around 7% through 2026. CROs offer services supporting the process of veterinary drug discovery, clinical trials and toxicology studies in veterinary pharmaceutical companies. Thus, the adoption of animal models, including mice, is significantly growing at a rapid pace by these organizations. In addition, the contract research organizations are being increasingly preferred for customized research by the pharmaceutical companies in order to reduce the production cost and time.

Increasing healthcare expenditure in the China will create lucrative growth opportunity for the industry

China mice model market size was over USD 275 million in 2019 on account of the continuous rise in population suffering with chronic disorders that is stimulating the demand for effective therapeutics. As a result, there is an increase in number of research and development labs in the country. Several industry participants in the country are investing in expanding the demand for mice model in the country.

Key players are adopting several business strategies to capture significant the market share

Some of the companies operating in the market are Charles River, Envigo, Taconic Biosciences Inc., genOway, Janvier Labs and Hera BioLabs among others. Increasing focus of the market leaders on manufacturing and developing innovative products for effective treatment of diseases will provide significant growth opportunities. These participants are proposing strategic acquisitions, mergers, collaborations and partnerships in order to launch new models of mice and strengthen their industrial position.

Authors: Sumant Ugalmugle, Rupali Swain